Traditional computing infrastructure faces bottlenecks when managing massive datasets and complex simulations, often delaying critical life science research. Viridien addresses this challenge with its scalable, results-driven "Outcome as a Service" (OaaS) model, offering cloud-based HPC resources tailored to specific research needs.
Viridien's model optimises computational workflows, reduces drug discovery timelines, and lowers costs by providing access to advanced simulations and parallel processing capabilities. Researchers benefit from Viridien’s HPC expertise, which improves operational efficiency and enables faster market entry for new drugs. By focusing on achieving specific research outcomes rather than raw computing resources, OaaS minimises hidden costs while delivering measurable results.